Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea
· Delayed Price · Currency is KRW 7,230.00
-10.00 (-0.14%)
At close: Mar 6, 2026
Wonbiogen Revenue
Wonbiogen had revenue of 9.22B KRW in the quarter ending September 30, 2025, with 34.33% growth. This brings the company's revenue in the last twelve months to 34.38B, up 17.33% year-over-year. In the year 2024, Wonbiogen had annual revenue of 30.44B with 2.79% growth.
Revenue (ttm)
34.38B
Revenue Growth
+17.33%
P/S Ratio
1.43
Revenue / Employee
446.51M
Employees
77
Market Cap
49.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.44B | 824.93M | 2.79% |
| Dec 31, 2023 | 29.61B | 2.87B | 10.72% |
| Dec 31, 2022 | 26.75B | 9.03B | 50.94% |
| Dec 31, 2021 | 17.72B | 5.70B | 47.46% |
| Dec 31, 2020 | 12.02B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 133.05B |
| SCL Science | 16.32B |
| MEDYSSEY Co.,Ltd | 10.60B |
| Plasmapp | 6.20B |
| Sewoon Medical | 62.13B |
| JW Shinyak | 76.02B |
| OSTEONIC | 42.11B |
| Billions | 30.71B |